Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder
Status:
Withdrawn
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
In this study, patients with major depressive disorder (MDD) who have insomnia symptom are
treated with Seroquel XR in an open-label manner for a 4-week period with repeated
measurements of insomnia symptoms and sleep parameters using polysomnography.